To detect clinically significant hypercapnia promptly, the control intervals for spirometry should be narrowed in patients with COPD stages 3 and 4 with declining FVC% or FEV1% below critical ...

Around 15,000 Kiwis - a number of them Māori and Pasifika - living with chronic obstructive pulmonary disease (COPD), the ...

Changes in people’s voices recoded on a smartphone can signal a serious flare up in symptoms of chronic obstructive pulmonary ...

COPD and BPD: Inhalation of Live Lactobacilli Lessens Lung Inflammation and Improves Lung Function Aug. 21, 2024 — In preclinical models, the inhalation of a mixture of living Lactobacilli ...

GSK (NYSE:GSK) announced Friday that its asthma therapy Nucala (mepolizumab) reached the main goal in a Phase 3 trial for ...

COPD by GOLD 2023 criteria using the CAT score accounted for approximately 57 per cent of the diagnosed prevalent cases, indicating delayed diagnosis eventually leading to severe stages of the ...

Changes in people's voices recorded on a smartphone can signal a serious flare up in symptoms of chronic obstructive ...

AstraZeneca executives say they are “not worried” that the failure of tozorakimab in a phase 2 chronic obstructive pulmonary ...

IL-33 monoclonal antibody failed a Phase 2a study in chronic obstructive pulmonary disease, though the company noted there ...

Sanofi and Regeneron’s superstar anti-inflammatory biologic Dupixent is on a roll. | It was a busy day for Sanofi and ...

In a report released today, Ram Selvaraju from H.C. Wainwright reiterated a Buy rating on Verona Pharma (VRNA – Research Report), with a ...